QualityStocks News - MIT Holding, Inc. (MITD) Introduces First-of-its-Kind In-Home Concierge Medical Service

QualityStocks would like to highlight MIT Holding, Inc. (OTCQB: MITD). The company, through its agents, facilitators and contractual obligations, offers professional outpatient medical care with ambulatory infusion therapies, home infusion services, and medical equipment delivery. The company is also pursuing government contacts to obtain approval to import pharmaceutical products into the Americas.

In the company’s news:

Imagine you’re in the hospital, preparing to check-out the following day. Knowing the recovery ahead will require certain accommodations, you phone downstairs to the concierge desk and say, “I’m checking out tomorrow; would you please make all the arrangements for my recovery at home?”
If that doesn’t sound like the steps taken by you or a loved one following release from a hospital in the past, it’s because the service didn’t exist. Until now.

With MIT Holding’s patient-centered approach, you can call and request comprehensive in-home concierge services designed to accelerate and ease your recovery. There are many stages in the illness process, and MIT Holding is emerging as a single source provider of medical services for patients making the vital transition from stage three to stages four and five.

In 1965, research scientist Edward Suchman defined the stages of illness and the transition between them as:

1) The symptom experience stage
2) The sick role stage
3) The medical care stage
4) The dependent patient stage
5) The recovery or rehabilitation stage

Management at MIT Holding studied the five stages in today’s healthcare system and found that the two most crucial yet most ignored stages were four and five. Due to the fact that the fourth and fifth stages are often completed in the patient’s home, these final stages are the least studied. Other than the typical “see me in two weeks” checkup and physical therapy (if needed), there is limited professional medical involvement in the patient’s transition through recovery and rehabilitation.

The lack of services in the final stages – which MIT Holding deems the most stressful, because recovery is now on the patient’s shoulders – representing a dire need within the healthcare industry. Patients often feel a loss of control and sense of guilt as they become dependent on family members and friends for assistance. Some situations even introduce humiliation to the equation when a patient is bed ridden and in need of basic sanitary assistance.
When a loved one tells the patient they look great, the patient may shrug it off as empty words of kindness. When the professional tells them the same thing it tends to have a positive meaning and begins to incubate recovery on a mental level for the patient, as well as physical. Similarly, loved ones urging the patient to take their medication or rehabilitation is often dismissed by a patient. The same instructions coming from a healthcare professional are heeded as “doctor’s orders” and followed.

Following years of surveys and interviews with past and current patients, MIT Holding developed its concept of single source medical services to address these stages required for recovery and rehabilitation. By introducing MIT Holding’s medical professionals into the equation, the company aims to instill within each patient a renewed sense of dignity, responsibility, and focused level of control over their recovery. With the emotions and stress reduced, the result is quicker recovery and confidence building steps toward regained independence.

Through its research, MIT Holding also realized that by working directly with hospital discharge planners prior to release, the patient would experience a seamless transition from hospital to home. MIT Holding eliminates discharge hassles such as dealing with the bureaucratic hassles of the insurance companies, pharmacy, medical equipment suppliers and specialized transportation needs. MIT professionals have been trained and accredited to quickly and efficiently execute these arrangements on behalf of the patient.

The Centers for Disease Control (CDC) reports that the number of first-time pneumonia cases in the U.S. exceeds 35 million annually. The typical hospital stay is roughly five days followed by home recovery of four to six weeks depending on the severity of the case. Astoundingly, the recovery period alone can cost approximately $12,000 to $14,000, with no complications.

MIT Holding’s services drastically reduce these costs. Using a patient with pneumonia as an example, here is how the company’s solution works.
On the day of discharge from the hospital, the patient is met by an MIT Holding staff member, introduced to the company’s streamlined recovery process, and informed of the medical needs for their recovery period. The staff member will also explain to the patient all the options covered by their insurance and what will be the patient’s responsibility.

Pneumonia requires an antibiotic infusion often weekly for a four- to six-week period. Using MIT Holding’s services, the patient has the option of in-home care or access to one of MIT Holding’s local clinics to receive the treatment, which require a two- to four-hour administration session. Whether in the patient’s home or in the clinic, MIT Holding’s professional staff interacts with the patient to determine their individual needs throughout the treatment.
The staff also lobbies on the patient’s behalf for ancillary recovery needs. For example, patients recovering from pneumonia are advised to sleep in a reclined position. MIT Holding can verify if the insurance carrier will pay for a temporary rental of a hospital bed or medical recliner through recovery – and then make arrangements for its delivery and pick up. Should the patient live alone, MIT Holding can arrange for additional daily help as needed to maintain a sanitary recovery environment. In addition, the company’s compound pharmacy will deliver the antibiotics and other oral medication directly to the patient.

The extended time and personal care spent with the patient ensures that each patient receives every benefit to which they are entitled or choose to purchase for the most comfortable recovery possible. MIT Holding works with each patient to ease the burdens of recovery. Simply put MIT Holding deals in solutions – not problems!

MIT Holding has learned and proven that by extending superior care to the patient on multiple fronts, the company itself will benefit through multiple, growing revenue streams. Beta tests of this approach have shown an average increase in sales of up to 27% on a typical patient interaction – and the company is just getting started implementing its innovation into the U.S. healthcare system. Its potential has yet to be seen or achieved.
MIT Holding is pioneering the future of healthcare, positioned as the first-of-its-kind single source provider of medical services stemming from a convenient, all-inclusive concierge concept with no additional cost to the patient.

About QualityStocks

QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.

To sign up for The QualityStocks Daily Newsletter, please visit www.QualityStocks.net  

To connect with QualityStocks via Facebook, please visit http://Facebook.com/QualityStocksPage

To connect with QualityStocks via Twitter, please visit http://Twitter.com/QualityStocks

Please read FULL disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.net   

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.